Cases
DLA Piper has advised Harper & Vedel on its sale to XPartners
Insights
The Danish Medicines Agency provides regulatory guidance on the EU regulations MDR, IVDR and AI Act
Cases
DLA Piper has advised the owners of Cenger in connection with a sale to Proclinic
Newsletter
Danish Life Science News January 2025
Newsletter
Danish act on implementation in Danish law of the EU Corporate Sustainability Reporting Directive (CSRD)
EU's 14th package of sanctions against Russia
Insights
Great news for corporate sustainability and ESG: European Parliament has adopted proposal for EU Corporate Sustainability Due Diligence Directive (CSDDD)
Insights
TÜV SÜD Danmark ApS designated as a notified body for medical devices in Denmark
Insights
New bill requires companies to maintain emergency stocks and report their stock of critical medicines
Insights
US government reminds non-US companies of requirement to comply with US sanctions and export controls
Insights
Company gets a fine for misleading advertising of their laser machine
New Danish board for health apps on its way
Newsletter
New guide from ENLI about information material and medical devices
Cases
DLA Piper assisted Curasight with global license of uTRACE® for use in prostate cancer
Newsletter
New ruling from CJEU clarifies scope of advertising of medicinal products
DLA Piper har bistået sælgerne af BASE life science A/S med salg af samtlige kapitalandele til Infosys.
Insights
Time-limit for submitting annual reports now permanently extended to six months
Insights
Six months with the new Danish act on screening of foreign direct investments - FDI act
Inspection visits in dual-use cases and EU sanctions
Insights
